The largest hospital for infectious diseases and COVID-19 patients, the modular Leishenshan Hospital was created with "China Speed," surprising the world with its 14-day construction.
CSADI and Dassault Systèmes are using the 3DEXPERIENCE platform's simulation capabilities to simulate virus contamination and diffusion within the hospital's ventilation system and to counteract the negative effects from unplanned ventilation risks.
As a strategic partner of Dassault Systèmes in China, CSADI undertook the design of Leishenshan Hospital. Avoiding contamination of nearby environments is a key consideration for CSADI, especially the minimisation of cross-infection in the hospital and any impacts on external communities, crowds and surroundings.
To this end, Dassault Systèmes has donated SIMULIA XFlow software, powered by the 3DEXPERIENCE platform, to CSADI to simulate indoor and outdoor fluids, virus dispersal in ventilation systems, as well as other projects within Leishenshan Hospital.
Dassault Systèmes provide business and people with collaborative 3D virtual environments to imagine sustainable innovations.
Decoy Therapeutics expands antiviral platform into Ebola and filovirus research
ABL Diagnostics selected to acquire TEXCELL operations
Aptamer Group launches Optimer-based Ebola diagnostic programme
EDX Medical to provide molecular profiling services to Astron Health
Sanofi appoints new global head of Research & Development Pharma
Lakewood-Amedex expands intellectual property portfolio with Australian Bisphosphocin patent
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
RedHill Biopharma advancing opaganib options for Ebola outbreak
Transgene to present preclinical TG-MVA mpox vaccine data at World Congress on Infectious Diseases
Hyundai Bioscience says XAFTY available for Ebola and Hantavirus treatment
Apotex and Cumberland Pharmaceuticals to integrate their US branded businesses